However, despite its promising character, the development of specific inhibitors of DNMT1/protein-x interactions requires the identification of tumor suppressor-like neutral-tumorigenic-specific inhibition of DNMT1/protein-x interaction or anti-tumorigenic-specific disruption of certain DNMT1/protein-x interactions. Here, DNMT1 is linked to neoplasm.